Replies to post #205439 on Biotech Values

[DewDiligence]

...for all we know the risk of the drug at that point might be greater than the risk of stopping it...

If cost were no object, which decision would you make for yourself or a family member? (I know what my answer would be.)

Moreover, MRK's head of commercial operations, Adam Schechter, said on today's CC that the 24-month schedule in the FDA label will almost certainly not be an impediment to reimbursement for longer durations.